Millipede AspiRation for Revascularization in Stroke (MARRS) Study
N/A
Completed
NCT05714501
| Condition | Acute Ischemic Stroke |
|---|
| Phase | N/A |
|---|
| Sponsor | Perfuze |
|---|
| Status | Completed |
|---|
| Enrollment | 235 participants |
|---|
| Interventions | Millipede System |
|---|
| Start date | Oct 9, 2023 |
|---|
| Completion date | Mar 8, 2025 |
|---|
| Results posted | Jul 10, 2026 |
|---|
Summary
The objectives of the study are to examine the performance and safety characteristics of the Millipede System when used for revascularization of patients with acute ischemic stroke due to Large Vessel Occlusions (LVOs) and to record associated clinical outcomes.
ITT Cohort: Rate of Core Lab-adjudicated Reperfusion Success Within Three Passes
Intraprocedural · Participants
| Millipede System | 160 Participants |
|---|
ITT Cohort: Primary Safety Outcome
From Day 0 (procedure) through to the 90 Day visit. · Participants
| Millipede System | 55 Participants |
|---|
| Millipede System | 4 Participants |
|---|
| Millipede System | 6 Participants |
|---|
| Millipede System | 25 Participants |
|---|
ITT Cohort: Supplementary Analysis of Primary Effectiveness Endpoint
Intraprocedural · Participants
| Millipede System | 132 Participants |
|---|
Open in BENITIONS
View on ClinicalTrials.gov
Other trials for this condition
All trials
This page summarises publicly available data from ClinicalTrials.gov. It is not medical advice and not investment advice. Always consult a qualified healthcare professional.